SCHEMBL30798285

SCHEMBL30798285

Cc1ccc(S(=O)(=O)n2ccc3c(N[C@H]4C[C@@H](NC(=O)OC(C)(C)C)C4)c(N)cnc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
NAMPT P43490 3/20 0.37
BTK Q06187 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
RORC P51449 6/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
JAK1 P23458 3/20 0.33
PIK3CD O00329 1/20 0.33
JAK2 O60674 1/20 0.33
KLK7 P49862 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26638016 1.00 KMT2A (0.38) KMT2AMEN1POLBNAMPTBTK
SCHEMBL26638100 1.00 KMT2A (0.38) KMT2AMEN1POLBNAMPTBTK
SCHEMBL29819410 0.90 NAMPT (0.37) KMT2AMEN1POLBNAMPTBTK
SCHEMBL30798172 0.88 NAMPT (0.36) KMT2AMEN1POLBNAMPTBTK
SCHEMBL26638095 0.88 NAMPT (0.36) KMT2AMEN1POLBNAMPTBTK
SCHEMBL26638008 0.88 NAMPT (0.36) KMT2AMEN1POLBNAMPTBTK
SCHEMBL30797961 0.88 NAMPT (0.36) KMT2AMEN1POLBNAMPTBTK
SCHEMBL2277837 0.88 BTK (0.42) KMT2ANAMPTBTKL3MBTL1RORC
SCHEMBL2291394 0.88 BTK (0.42) KMT2ANAMPTBTKL3MBTL1RORC
SCHEMBL2293606 0.88 BTK (0.42) KMT2ANAMPTBTKL3MBTL1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118406052-A Tricyclic JANUS kinase 1 inhibitors and compositions and methods thereof 凌科药业(杭州)有限公司 2024-07-30 CN disclosed
CN-113396150-B Tricyclic JANUS kinase 1 inhibitors and compositions and methods thereof 凌科药业(杭州)有限公司 2024-03-12 CN disclosed